Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Boots Healthcare Intl.

This article was originally published in The Tan Sheet

Executive Summary

UK retailer/manufacturer to use Bioprogress Technology's XGel soft capsule system under deal announced Nov. 28. Separately, Boots appoints Chuo Bussan Intl. as distributor for Clearasil in Japan, effective Dec. 3. BHI expects to expand Clearasil distribution in 130 countries where Boots products are sold. Line likely will be extended in fiscal 2002 to address greater range of skin conditions, such as psoriasis, firm says. Boots, which purchased Clearasil from P&G last year, recently named Novartis as distributor in U.S. and Canada (1"The Tan Sheet" May 21, In Brief)...

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts